Osmotica Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for OSMOTICA, and what generic and branded alternatives to OSMOTICA drugs are available?
OSMOTICA has nine approved drugs.
Drugs and US Patents for Osmotica
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Osmotica | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205327-005 | Jul 28, 2017 | AB | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Osmotica Pharm Us | RELEXXII | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 216117-002 | Jun 23, 2022 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Osmotica Pharm Us | RELEXXII | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 216117-007 | Jun 23, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Osmotica | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205327-004 | Jul 28, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Osmotica Pharm Us | NIFEDIPINE | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 077127-003 | Oct 3, 2007 | AB2 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Osmotica Pharm Us | DONEPEZIL HYDROCHLORIDE | donepezil hydrochloride | TABLET;ORAL | 203114-001 | Jan 26, 2016 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Osmotica
Similar Applicant Names
Here is a list of applicants with similar names.